Oscar Health’s CEO buys $12 million in shares, boosting the stock and investor confidence. Learn how this move could reshape health‑tech ownership and market dynamics.
Wells Fargo’s recent institutional sell‑offs, aggressive analyst cuts and geopolitical risk hint at a fragile earnings outlook—what investors should know.
Discover how Apollo Global’s April earnings preview, investor alerts, leadership changes and high‑yield strategy could reshape its market stance and shareholder influence.
Huatai Securities eyes Japan expansion, keeping a solid target price—discover how the brokerage’s move boosts growth and offers investors a promising play in China’s evolving finance sector.
VersaBank’s AGM shows a unanimous board re‑election, steady governance, and a low 0.16 % dividend—ideal for investors prioritizing stability over high payouts.
Fiserv faces analyst downgrades, activist pressure, and a steep price decline—yet new Matera partnership and JPMorgan exec hire signal strategic moves to regain investor confidence.